Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

被引：0

作者：

Mingot-Castellano, Maria Eva ^{[1
]}

Mellado, Patricia Alcalde ^{[1
]}

Urena, Laura Entrena ^{[2
]}

Izquierdo, Maria Cristina Pascual ^{[3
]}

Zafra, Denis ^{[4
]}

Hinryk, Mariana Canaro ^{[5
]}

Bastida, Jose Maria ^{[6
]}

Bernat, Silvia Bernat ^{[7
]}

Carballeira, Daniel Martinez ^{[8
]}

Miranda, Isabel Caparros ^{[9
]}

Garcia, Amalia Cuesta ^{[10
]}

Lakhwani, Sunil ^{[11
]}

Gonzalez, Blanca Sanchez ^{[12
]}

Maldonado, Marta Canet ^{[13
]}

Solano, Maria Carmen Gomez del Castillo ^{[14
]}

Culebra, Marta Garcia ^{[1
]}

Rodriguez, Beatriz Chiclana ^{[1
]}

Fernanadez-Villalobos, Manuel ^{[15
]}

Llorca, Paula Sanchez ^{[16
]}

Monsonis, Lola Piquer ^{[17
]}

Vazquez, Carlos Puerta ^{[18
]}

Montes, Rocio Perez ^{[10
]}

Garcia-Pallarols, Francesc ^{[19
]}

Valcarcel, David ^{[20
]}

Amador, Begona Pedrote ^{[1
]}

机构：

[1] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Seville, Spain

[2] Hosp Univ Virgen Nieves, Granada, Spain

[3] Hosp Univ Gregorio Maranon, Serv Hematol, Inst Invest Gregorio Maranon, Madrid, Spain

[4] Hosp Univ 12 Octubre, Madrid, Spain

[5] Hosp Univ Son Espases, Hematol Dept, IdISBa, Palma De Mallorca, Spain

[6] Hosp Clin Univ Salamanca, Hematol Dept, IBSAL, Salamanca, Spain

[7] Hosp Univ Plana, Villarreal, Castellon, Spain

[8] Hosp Univ Cent Asturias, Oviedo, Asturias, Spain

[9] Univ Malaga, E-29071 Malaga, Spain

[10] Hosp Sierrallana, Torrelavega, Spain

[11] Hosp Univ Canarias, San Cristobal la Laguna, Spain

[12] Hosp Mar, Hematol Dept, Barcelona, Spain

[13] Hosp Universitari Mutua Terrassa, Terrassa, Barcelona, Spain

[14] Complexo Hospitalario Univ A Coruna, La Coruna, Spain

[15] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[16] Hosp 12 Octubre, Madrid, Spain

[17] Hosp Univ Son Espases, Mallorca, Spain

[18] Complejo Asistencial Univ Salamanca CAUSA, IBSAL, Salamanca, Spain

[19] Hosp Mar, Barcelona, Spain

[20] Hosp Univ Hebron, Dept Hematol, Barcelona, Spain

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-201847

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3948 / 3949

页数：2

共 37 条

[1] Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience
Crickx, Etienne
Ebbo, Mikael
Riviere, Etienne
Souchaud-Debouverie, Odile
Terriou, Louis
Audia, Sylvain
Ruivard, Marc
Asli, Bouchra
Marolleau, Jean-Pierre
Meaux-Ruault, Nadine
Gerfaud-Valentin, Mathieu
Audeguy, Philippe
Hamidou, Mohamed
Corm, Selim
Delbrel, Xavier
Fontan, Jean
Lebon, Delphine
Mausservey, Christelle
Moulis, Guillaume
Limal, Nicolas
Michel, Marc
Godeau, Bertrand
Mahevas, Matthieu
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (04) : 883 - 889
[2] SAFETY AND EFFICACY/EFFECTIVENESS OF SECOND-LINE TREATMENTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW OF THE LITERATURE
Cetin, Karynsa
Callaghan, Fiona
Fryzek, Jon P.
Bylsma, Lauren C.
Bezold, Carla
Mehta, Bhakti
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E400 - E400
[3] SAFETY AND EFFICACY/EFFECTIVENESS OF SECOND-LINE TREATMENTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW OF THE LITERATURE
Cetin, K.
Callaghan, F.
Fryzek, J.
Bylsma, L.
Bezold, C.
Mehta, B.
HAEMATOLOGICA, 2016, 101 : 587 - +
[4] Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
Gonzalez-Porras, Jose R.
Godeau, Bertrand
Carpenedo, Monica
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 9
[5] Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
Michel, Marc
Wasser, Jeffrey
Godeau, Bertrand
Aledort, Louis
Cooper, Nichola
Tomiyama, Yoshiaki
Khellaf, Mehdi
Wang, Xuena
ANNALS OF HEMATOLOGY, 2015, 94 (12) : 1973 - 1980
[6] Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
Marc Michel
Jeffrey Wasser
Bertrand Godeau
Louis Aledort
Nichola Cooper
Yoshiaki Tomiyama
Mehdi Khellaf
Xuena Wang
Annals of Hematology, 2015, 94 : 1973 - 1980
[7] Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
Carpenedo, Monica
Baldacci, Erminia
Barate, Claudia
Borchiellini, Alessandra
Buccisano, Francesco
Calvaruso, Giuseppina
Chiurazzi, Federico
Fattizzo, Bruno
Giuffrida, Gaetano
Rossi, Elena
Palandri, Francesca
Scalzulli, Potito Rosario
Siragusa, Sergio Mario
Vitucci, Angelantonio
Zaja, Francesco
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
[8] Thrombopoietin receptor agonists as second-line therapy in splenectomy-eligible persistent immune thrombocytopenia: a case series
Vianello, Fabrizio
D'Amore, Fabio
Lombardi, Anna M.
Caputo, Ilaria
Friziero, Alberto
Da Dalt, Gianfranco
BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (06) : 295 - 299
[9] Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia
Goshua, George
Sinha, Pranay
Pischel, Lauren
Lee, Alfred Ian
Cuker, Adam
BLOOD, 2021, 138
[10] THROMBOPOIETIN RECEPTOR AGONISTS AND OTHER SECOND-LINE THERAPIES FOR IMMUNE THROMBOCYTOPENIA: A NARRATIVE REVIEW WITH A FOCUS ON DRUG ACCESS IN CANADA
Britto, Joanne
Holbrook, Anne
Sun, Haowei
Cserti-Gazdewich, Christine
Prokopchuk-Gauk, Oksana
Hsia, Cyrus
Khamisa, Karima
Yenson, Paul R.
Sholzberg, Michelle
Olney, Harold J.
Shivakumar, Sudeep
Jones, David
Merkeley, Hayley
Costello, Jacqueline
Jamula, Erin
Arnold, Donald M.
CLINICAL AND INVESTIGATIVE MEDICINE, 2024, 47 (01): : 13 - 22

← 1 2 3 4 →